Particle.news
Business ❯Pharmaceutical Industry
Drug Pricing Eli Lilly Pricing Strategies Drug Development Novo Nordisk Drug Approval Stock Market Obesity Treatments Telehealth Services Pricing Branding Drug Alternatives Drug Launches Drug Efficacy Product Launches Weight Loss Drug Market RSV Vaccines GLP-1 Market Weight Loss Market Anti-Obesity Drugs Product Development Vaccine Market Product Launch Weight Loss Drugs Stock Performance Obesity Drugs Eli Lilly vs Novo Nordisk Research and Development Drug Sales Generic Drugs
The Danish drugmaker expects U.S. Wegovy sales to recover in H2 2025 following FDA enforcement and a new CVS formulary deal, despite lowering growth forecasts due to compounding competition.
